Shopping Cart 0
Cart Subtotal
AED 0

Implantable Drug Delivery Devices Market (Drug Infusion Pumps, Drug Delivery Devices, Bio-Absorbable Stents, Coronary Drug Eluting Stents, Brachytherapy Seeds, Contraceptive Drug Delivery Implants and Others) for Oncology, Contraception, Cardiovascular, Ophthalmology, Inflammatory Conditions, Diabetes and Other End-users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 15410

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 23117

Details

The report covers detailed analysis and forecast for the implantable drug delivery devices market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD billion). The study includes a comprehensive view of the market with the review of market drivers, restraint, and opportunities. It also offers the level of impact of drivers and restraints on the implantable drug delivery devices market between 2015 and 2021. The study included a detailed competitive scenario and product portfolio of key vendors. The report evaluates Porters Five Forces model to analyze the different factors affecting the growth of the implantable drug delivery devices market. Moreover, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by product, end-user, and region. The report includes detailed segmentation of implantable drug delivery devices market based on product, end-user, and region. Implantable drugs infusion pumps are the key product in the implantable drug delivery devices market. On the basis of end-user segment, the market can be classified into Oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and others end-users. Major regional segment analyzed in this report include Asia Pacific, North America, Europe, Latin America and the Middle East Africa with its further bifurcation into major countries including China, Japan, India, U.S. Germany, France, UK, and Brazil. The report provides detailed competitive outlook including market share and company profiles of the key players operating in the global market. Some of the key participants in the report include Bausch Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others. This report segments the global implantable drug delivery devices market as follows: Global Implantable Drug Delivery Devices Market: Product Segment Analysis Drug Infusion Pumps Drug Delivery Devices Bio-Absorbable Stents Coronary Drug Eluting Stents Brachytherapy Seeds Contraceptive Drug Delivery Implants Others Global Implantable Drug Delivery Devices Market: End-user Segment Analysis Oncology Contraception Cardiovascular Ophthalmology Inflammatory Conditions Diabetes Others Global Implantable Drug Delivery Devices Market: Regional Segment Analysis North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

READ MORE

Table Of Content

Scope

Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global Implantable Drug Delivery Devices market, 2015 2021 (USD Billion) 2.2. Global Implantable Drug Delivery Devices market : Snapshot Chapter 3. Implantable Drug Delivery Devices Market Dynamics 3.1. Introduction 3.2. Market drivers 3.2.1. Global Implantable Drug Delivery Devices market drivers: Impact analysis 3.2.2. Increasing Aged Population Globally 3.2.3. Increasing Demand For Minimally Invasive Procedures 3.3. Market restraints 3.3.1. High Price of Implantable Drug Delivery Devices 3.4. Opportunities 3.4.1. Introduction of New and More Effective Implantable Drug Delivery Devices 3.5. Porters five forces analysis 3.5.1. Bargaining power of suppliers 3.5.2. Bargaining power of buyers 3.5.3. Threat from new entrants 3.5.4. Threat from new substitutes 3.5.5. Degree of competition 3.6. Market attractiveness analysis 3.6.1. Market attractiveness analysis, by product segment 3.6.2. Market attractiveness analysis, by End-user segment 3.6.3. Market attractiveness analysis, by regional segment Chapter 4. Global Implantable Drug Delivery Devices Market Competitive Landscape 4.1. Company Market Share Analysis 4.1.1. Global Implantable Drug Delivery Devices market: company market share, 2015 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Product Launch 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures 4.2.4. Research and Development, Product and Regional Expansion 4.3. Price Trend Analysis 4.4. Product Portfolio 4.5. Patent Analysis (2011-2016) 4.5.1. Patent Trend 4.5.2. Patent Share by company 4.5.3. By Region Chapter 5. Global Implantable Drug Delivery Devices Market Product Segment Analysis 5.1. Global Implantable Drug Delivery Devices market: Product overview 5.1.1. Global Implantable Drug Delivery Devices market revenue share, by product, 2015 and 2021 5.2. Drug Infusion Pumpsr 5.2.1. Global Drug Infusion Pumpsr market, 2015 2021(USD Billion) 5.3. Drug Delivery Devices 5.3.1. Global Drug Delivery Devices market, 2015 2021(USD Billion) 5.4. Bio-Absorbable Stents 5.4.1. Global Bio-Absorbable Stents market, 2015 2021(USD Billion) 5.5. Coronary Drug Eluting Stents 5.5.1. Global Coronary Drug Eluting Stents market, 2015 2021(USD Billion) 5.6. Brachytherapy Seeds 5.6.1. Global Brachytherapy Seeds market, 2015 2021(USD Billion) 5.7. Contraceptive Drug Delivery Implants 5.7.1. Global Contraceptive Drug Delivery Implants market, 2015 2021(USD Billion) 5.8. Others 5.8.1. Global other product market , 2015 2021(USD Billion) Chapter 6. Global Implantable Drug Delivery Devices Market End-user Segment Analysis 6.1. Global Implantable Drug Delivery Devices market: End-user overview 6.1.1. Global Implantable Drug Delivery Devices market revenue share, by End-user, 2015 and 2020 6.2. Oncology 6.2.1. Global Implantable Drug Delivery Devices market for Oncology, 2015 2021 (USD Billion) 6.3. Contraception 6.3.1. Global Implantable Drug Delivery Devices market for Contraception, 2015 2021(USD Billion) 6.4. Cardiovascular 6.4.1. Global Implantable Drug Delivery Devices market for Cardiovascular, 2015 2021 (USD Billion) 6.5. Ophthalmology 6.5.1. Global Implantable Drug Delivery Devices market for Ophthalmology, 2015-2021(USD Billion) 6.6. Inflammatory Conditions 6.6.1. Global Implantable Drug Delivery Devices market for Inflammatory Conditions, 2015-2021(USD Billion) 6.7. Diabetes 6.7.1. Global Implantable Drug Delivery Devices market for Diabetes, 2015-2021(USD Billion) 6.8. Others 6.8.1. Global Implantable Drug Delivery Devices market for other End-user , 2015 2021 (USD Billion) Chapter 7. Global Implantable Drug Delivery Devices Market Regional Segment Analysis 7.1. Global Implantable Drug Delivery Devices market: Regional overview 7.1.1. Global Implantable Drug Delivery Devices market revenue share, by region, 2015 and 2021 7.2. North America 7.2.1. North America Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.2.2. North America Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.2.3. U.S. 7.2.3.1. U.S. Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.2.3.2. U.S. Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.3. Europe 7.3.1. Europe Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.3.2. Europe Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.3.3. Germany 7.3.3.1. Germany Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.3.3.2. Germany Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.3.4. France 7.3.4.1. France Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.3.4.2. France Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.3.5. UK 7.3.5.1. UK Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.3.5.2. UK Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific Implantable Drug Delivery Devices market revenue, by product, 2015 2021, (USD Billion) 7.4.2. Asia Pacific Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021, (USD Billion) 7.4.3. China 7.4.3.1. China Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.4.3.2. China Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.4.4. Japan 7.4.4.1. Japan Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.4.4.2. Japan Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.4.5. India 7.4.5.1. India Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.4.5.2. India Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.5. Latin America 7.5.1. Latin America Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.5.2. Latin America Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.5.3. Brazil 7.5.3.1. Brazil Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.5.3.2. Brazil Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021 (USD Billion) 7.6. Middle East and Africa 7.6.1. Middle East and Africa Implantable Drug Delivery Devices market revenue, by product, 2015 2021 (USD Billion) 7.6.2. Middle East and Africa Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) Chapter 8. Company Profile 8.1. Bausch Lomb Inc. 8.1.1. Overview 8.1.2. Financials 8.1.3. Product portfolio 8.1.4. Business strategy 8.1.5. Recent developments 8.2. Medtronic Inc. 8.2.1. Overview 8.2.2. Financials 8.2.3. Product portfolio 8.2.4. Business strategy 8.2.5. Recent developments 8.3. Boston Scientific Corporation 8.3.1. Overview 8.3.2. Financials 8.3.3. Product portfolio 8.3.4. Business strategy 8.3.5. Recent developments 8.4. Arrow International 8.4.1. Overview 8.4.2. Financials 8.4.3. Product portfolio 8.4.4. Business strategy 8.4.5. Recent developments 8.5. Theragenics 8.5.1. Overview 8.5.2. Financials 8.5.3. Product portfolio 8.5.4. Business strategy 8.5.5. Recent developments 8.6. Varian Medical Systems 8.6.1. Overview 8.6.2. Financials 8.6.3. Product portfolio 8.6.4. Business strategy 8.6.5. Recent developments 8.7. Allergan Inc. 8.7.1. Overview 8.7.2. Financials 8.7.3. Product portfolio 8.7.4. Business strategy 8.7.5. Recent developments 8.8. Merck 8.8.1. Overview 8.8.2. Financials 8.8.3. Product portfolio 8.8.4. Business strategy 8.8.5. Recent developments 8.9. Bayer Healthcare 8.9.1. Overview 8.9.2. Financials 8.9.3. Product portfolio 8.9.4. Business strategy 8.9.5. Recent developments 8.10. Abbott laboratories 8.10.1. Overview 8.10.2. Financials 8.10.3. Product portfolio 8.10.4. Business strategy 8.10.5. Recent developments

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The report covers detailed analysis and forecast for the implantable drug delivery devices market on a global and regional level from 2015 to 2021. The study offers historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD billion). The study includes a comprehensive view of the market with the review of market drivers, restraint, and opportunities. It also offers the level of impact of drivers and restraints on the implantable drug delivery devices market between 2015 and 2021. The study included a detailed competitive scenario and product portfolio of key vendors. The report evaluates Porters Five Forces model to analyze the different factors affecting the growth of the implantable drug delivery devices market. Moreover, the study encompasses a market attractiveness analysis, which provides the most attractive and least attractive market segments information by product, end-user, and region. The report includes detailed segmentation of implantable drug delivery devices market based on product, end-user, and region. Implantable drugs infusion pumps are the key product in the implantable drug delivery devices market. On the basis of end-user segment, the market can be classified into Oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and others end-users. Major regional segment analyzed in this report include Asia Pacific, North America, Europe, Latin America and the Middle East Africa with its further bifurcation into major countries including China, Japan, India, U.S. Germany, France, UK, and Brazil. The report provides detailed competitive outlook including market share and company profiles of the key players operating in the global market. Some of the key participants in the report include Bausch Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others. This report segments the global implantable drug delivery devices market as follows: Global Implantable Drug Delivery Devices Market: Product Segment Analysis Drug Infusion Pumps Drug Delivery Devices Bio-Absorbable Stents Coronary Drug Eluting Stents Brachytherapy Seeds Contraceptive Drug Delivery Implants Others Global Implantable Drug Delivery Devices Market: End-user Segment Analysis Oncology Contraception Cardiovascular Ophthalmology Inflammatory Conditions Diabetes Others Global Implantable Drug Delivery Devices Market: Regional Segment Analysis North America U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

READ MORE

Scope

Chapter 1. Introduction 1.1. Report description and scope 1.2. Research scope 1.3. Research methodology 1.3.1. Market research process 1.3.2. Market research methodology Chapter 2. Executive Summary 2.1. Global Implantable Drug Delivery Devices market, 2015 2021 (USD Billion) 2.2. Global Implantable Drug Delivery Devices market : Snapshot Chapter 3. Implantable Drug Delivery Devices Market Dynamics 3.1. Introduction 3.2. Market drivers 3.2.1. Global Implantable Drug Delivery Devices market drivers: Impact analysis 3.2.2. Increasing Aged Population Globally 3.2.3. Increasing Demand For Minimally Invasive Procedures 3.3. Market restraints 3.3.1. High Price of Implantable Drug Delivery Devices 3.4. Opportunities 3.4.1. Introduction of New and More Effective Implantable Drug Delivery Devices 3.5. Porters five forces analysis 3.5.1. Bargaining power of suppliers 3.5.2. Bargaining power of buyers 3.5.3. Threat from new entrants 3.5.4. Threat from new substitutes 3.5.5. Degree of competition 3.6. Market attractiveness analysis 3.6.1. Market attractiveness analysis, by product segment 3.6.2. Market attractiveness analysis, by End-user segment 3.6.3. Market attractiveness analysis, by regional segment Chapter 4. Global Implantable Drug Delivery Devices Market Competitive Landscape 4.1. Company Market Share Analysis 4.1.1. Global Implantable Drug Delivery Devices market: company market share, 2015 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Product Launch 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures 4.2.4. Research and Development, Product and Regional Expansion 4.3. Price Trend Analysis 4.4. Product Portfolio 4.5. Patent Analysis (2011-2016) 4.5.1. Patent Trend 4.5.2. Patent Share by company 4.5.3. By Region Chapter 5. Global Implantable Drug Delivery Devices Market Product Segment Analysis 5.1. Global Implantable Drug Delivery Devices market: Product overview 5.1.1. Global Implantable Drug Delivery Devices market revenue share, by product, 2015 and 2021 5.2. Drug Infusion Pumpsr 5.2.1. Global Drug Infusion Pumpsr market, 2015 2021(USD Billion) 5.3. Drug Delivery Devices 5.3.1. Global Drug Delivery Devices market, 2015 2021(USD Billion) 5.4. Bio-Absorbable Stents 5.4.1. Global Bio-Absorbable Stents market, 2015 2021(USD Billion) 5.5. Coronary Drug Eluting Stents 5.5.1. Global Coronary Drug Eluting Stents market, 2015 2021(USD Billion) 5.6. Brachytherapy Seeds 5.6.1. Global Brachytherapy Seeds market, 2015 2021(USD Billion) 5.7. Contraceptive Drug Delivery Implants 5.7.1. Global Contraceptive Drug Delivery Implants market, 2015 2021(USD Billion) 5.8. Others 5.8.1. Global other product market , 2015 2021(USD Billion) Chapter 6. Global Implantable Drug Delivery Devices Market End-user Segment Analysis 6.1. Global Implantable Drug Delivery Devices market: End-user overview 6.1.1. Global Implantable Drug Delivery Devices market revenue share, by End-user, 2015 and 2020 6.2. Oncology 6.2.1. Global Implantable Drug Delivery Devices market for Oncology, 2015 2021 (USD Billion) 6.3. Contraception 6.3.1. Global Implantable Drug Delivery Devices market for Contraception, 2015 2021(USD Billion) 6.4. Cardiovascular 6.4.1. Global Implantable Drug Delivery Devices market for Cardiovascular, 2015 2021 (USD Billion) 6.5. Ophthalmology 6.5.1. Global Implantable Drug Delivery Devices market for Ophthalmology, 2015-2021(USD Billion) 6.6. Inflammatory Conditions 6.6.1. Global Implantable Drug Delivery Devices market for Inflammatory Conditions, 2015-2021(USD Billion) 6.7. Diabetes 6.7.1. Global Implantable Drug Delivery Devices market for Diabetes, 2015-2021(USD Billion) 6.8. Others 6.8.1. Global Implantable Drug Delivery Devices market for other End-user , 2015 2021 (USD Billion) Chapter 7. Global Implantable Drug Delivery Devices Market Regional Segment Analysis 7.1. Global Implantable Drug Delivery Devices market: Regional overview 7.1.1. Global Implantable Drug Delivery Devices market revenue share, by region, 2015 and 2021 7.2. North America 7.2.1. North America Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.2.2. North America Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.2.3. U.S. 7.2.3.1. U.S. Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.2.3.2. U.S. Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.3. Europe 7.3.1. Europe Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.3.2. Europe Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.3.3. Germany 7.3.3.1. Germany Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.3.3.2. Germany Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.3.4. France 7.3.4.1. France Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.3.4.2. France Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.3.5. UK 7.3.5.1. UK Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.3.5.2. UK Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific Implantable Drug Delivery Devices market revenue, by product, 2015 2021, (USD Billion) 7.4.2. Asia Pacific Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021, (USD Billion) 7.4.3. China 7.4.3.1. China Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.4.3.2. China Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.4.4. Japan 7.4.4.1. Japan Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.4.4.2. Japan Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.4.5. India 7.4.5.1. India Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.4.5.2. India Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.5. Latin America 7.5.1. Latin America Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.5.2. Latin America Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) 7.5.3. Brazil 7.5.3.1. Brazil Implantable Drug Delivery Devices market revenue, by product, 2015 2021(USD Billion) 7.5.3.2. Brazil Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021 (USD Billion) 7.6. Middle East and Africa 7.6.1. Middle East and Africa Implantable Drug Delivery Devices market revenue, by product, 2015 2021 (USD Billion) 7.6.2. Middle East and Africa Implantable Drug Delivery Devices market revenue, by End-user, 2015 2021(USD Billion) Chapter 8. Company Profile 8.1. Bausch Lomb Inc. 8.1.1. Overview 8.1.2. Financials 8.1.3. Product portfolio 8.1.4. Business strategy 8.1.5. Recent developments 8.2. Medtronic Inc. 8.2.1. Overview 8.2.2. Financials 8.2.3. Product portfolio 8.2.4. Business strategy 8.2.5. Recent developments 8.3. Boston Scientific Corporation 8.3.1. Overview 8.3.2. Financials 8.3.3. Product portfolio 8.3.4. Business strategy 8.3.5. Recent developments 8.4. Arrow International 8.4.1. Overview 8.4.2. Financials 8.4.3. Product portfolio 8.4.4. Business strategy 8.4.5. Recent developments 8.5. Theragenics 8.5.1. Overview 8.5.2. Financials 8.5.3. Product portfolio 8.5.4. Business strategy 8.5.5. Recent developments 8.6. Varian Medical Systems 8.6.1. Overview 8.6.2. Financials 8.6.3. Product portfolio 8.6.4. Business strategy 8.6.5. Recent developments 8.7. Allergan Inc. 8.7.1. Overview 8.7.2. Financials 8.7.3. Product portfolio 8.7.4. Business strategy 8.7.5. Recent developments 8.8. Merck 8.8.1. Overview 8.8.2. Financials 8.8.3. Product portfolio 8.8.4. Business strategy 8.8.5. Recent developments 8.9. Bayer Healthcare 8.9.1. Overview 8.9.2. Financials 8.9.3. Product portfolio 8.9.4. Business strategy 8.9.5. Recent developments 8.10. Abbott laboratories 8.10.1. Overview 8.10.2. Financials 8.10.3. Product portfolio 8.10.4. Business strategy 8.10.5. Recent developments

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS